+7 495 640-17-71



Important news

“DNA-Technology” has completed the quality assessment study of SARS-CoV-2 molecular detection coordinated by Quality Control for Molecular Diagnostics (QCMD), UK. As the only Russian participant, “DNA-Technology” entered the target group and received an International Certificate confirming the quality of products: during quality assessment study a complete technological process chain was tested, including equipment and kits for RNA extraction and SARS-CoV-2 detection. The correct result was obtained in 100% of cases. Read the QCMD report.


Dear Partners,

With 2020 a year comes to its end, which is nothing less than a break in history of our planet. The pandemic directly or indirectly affected the entire mankind. In these times, we are blessed and thankful, having you as partners and friends on our side.


Dear colleagues!
We are pleased to present a new article “Semen microbiota: cluster analysis of real-time PCR data” by Voroshilina E.S., Doctor of Medical Sciences, Professor of the Department of Microbiology, Virology, and Immunology, Ural State Medical University, with a group of authors. They have conducted a cluster
analysis of semen microbiota of reproductive-age patients with infertility and healthy males using Androflor real-time PCR detection kit (DNA-Technology, Russia).
To read the full article, please follow the link.


All news

Dear partners,

“DNA-Technology” will be closed for public holidays from May 1 to May 10, 2021. We will resume our regular work on the May 11. Please, consider this information for your workflow plans.


We are pleased to present a new article "Differential Expression of Local Immune Response Genes in the Vagina: Implication for the Diagnosis of Vaginal Infections" by A. M. Savicheva with a group of authors from D.O. Ott Research Institute of Obstetrics, Gynecology and Reproductology and St. Petersburg State Pediatric Medical University, St. Petersburg.


Dear colleagues!
We are pleased to announce that we have created a new booklet "Femoflor: brief Introduction", which has collected answers to the most frequently asked clinical questions regarding the diagnosis of reproductive tract infections.
Why do you need Femoflor®, if you have a microscopy? What are the indications for Femoflor®-screen and Femoflor®-16 tests? How to read the report? Is it possible to use Femoflor® for men?


Dear colleagues!
We are glad to announce that our article "Diagnosis of the virus that causes COVID-19 by real-time PCR" by a team of authors (E. V. Goncharova, A. E. Donnikov, V. V. Kadochnikova , S. A. Morozov, M. N. Boldyreva, I. S. Galkina, D. V. Blinov) was published in the journal "Pharmacoeconomics. Modern Pharmacoeconomics and Pharmacoepidemiology". For more information please click the link below.


Dear colleagues!

We are glad to inform you that “DNA-technology” has started the kit production for detection of SARS-CoV-2 and SARS-CoV-like viruses using reverse transcription and real-time polymerase chain reaction(SARS-CoV-2/SARS-CoV). Kit is certified as CE-IVD, certificate # FD 9031-2020 dated 16.04.2020 RU-IVD, certificate # RZN 2020/9948 dated 01.04.2020. The kit meets the requirements of international documents for diagnostics of the coronavirus (Laboratory testing for coronavirus disease (COVID-19) in suspected human cases. Interim guidance. 19 March 2020. WHO).


Dear colleagues!

Meet us at MEDLAB 2020 in Dubai, February 3rd-6th at booth Z5.B48.
MEDLAB is one of the biggest clinical laboratory exhibition and congress, where leading companies are presented, spanning across the Middle East, Asia, East/West Africa, Europe and the US.
If you would like to set appointment with us there, please contact us in advance by email: info@dna-technology.com.


Dear Partners!

Thank you for being with us this year.
As 2019 comes to end, we want to take a moment to wish a Merry Christmas and a Happy New Year!
May upcoming year bring peace and happiness, innovations and development, prosperity and growth!


Dear colleagues!

We are pleased to announce that DNA Technology has participated in the First International Conference “World of Microbiome: Pregnancy, Birth and Infancy”, which was held in Milan, on 31 October – 02 November 2019.


Dear colleagues!

As usual we will be present at Medica, Hall 3 / E57.
We are pleased to announce presentation of new products, which will be exhibited at our booth. If you would like to set apointment with us there, please contact us in advance by email: info@dna-technology.com.